Curis, Inc.

CRIS ·Healthcare, Drug Manufacturers - General, United States
Valuation › AI Valuation

AI Valuation

AI-generated fair value estimate for this company.

AI Fair Value $1.05
Market Price $0.73
Undervalued By 30.5%

Method: Going-concern-adjusted net cash floor: $15.0M cash & investments / 2.09M shares = $7.18/share gross cash backing; applied an 85% discount for near-term dilutive-financing risk given a roughly $21.15M annual cash burn against limited remaining runway, yielding approximately $1.05-$1.08/share.

Reasoning: Curis has minimal revenue, heavy ongoing losses, and a market cap far below its reported cash balance, signaling the market is pricing in near-certain dilutive financing or going-concern risk; a standard DCF has no sustainable cash flows to discount, so a heavily risk-adjusted net-cash floor is the more defensible method.